Table 1.
Country | Sample size (confidence level) | Top two most commonly used adhesive foam dressings | Primary adhesive foam used most often | Average no. of adhesive foam dressings used per week | Attributes not being fulfilled† |
---|---|---|---|---|---|
USA/Canada‡ | 156 (90% ± 6·6%) | Mepilex (78%), Allevyn (63%) | Mepilex (44%) | 19 | Absorbency, length of wear time and prevention of maceration |
UK | 61 (90% ± 10·6%) | Allevyn (92%), Mepilex (80%) | Allevyn (52%) | 20 | Absorbency, ease of removing, patient comfort and prevention of maceration |
Germany | 90 (90% ± 8·7%) | Allevyn (67%), Tegaderm§ (47%) | Allevyn (39%) | 15 | Prevention of maceration |
Unpublished data, 3M Health Care, 2009.
Revealed by gap analysis: higher importance with lower satisfaction.
Includes 146 responders in the USA and 10 in Canada.
Predecessor formulation of the Tegaderm HP Adhesive Foam dressing tested in this study.